Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name RO6874281
Trade Name
Synonyms RG 7461|RG7461|Simlukafusp alfa|RO-6874281
Drug Descriptions

RO6874281 (Simlukafusp alfa) is a fusion protein consists of a human anti-fibroblast activation protein-alpha (FAP) antibody and an engineered interleukin-2, which may stimulate local immune response against FAP-positive tumor cells (NCI Drug Dictionary).

CAS Registry Number 1776942-10-9
NCIT ID C129383


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Bevacizumab + Obinutuzumab + RO6874281 Atezolizumab Bevacizumab Obinutuzumab RO6874281 0 1
Atezolizumab + Obinutuzumab + RO6874281 Atezolizumab Obinutuzumab RO6874281 0 1
Atezolizumab + RO6874281 Atezolizumab RO6874281 0 2
Pembrolizumab + RO6874281 Pembrolizumab RO6874281 0 1
RO6874281 RO6874281 0 1

Additional content available in CKB BOOST